Nguyen M, Guillozo H, Garabédian M, Balsan S
CNRS UA. 583 et Inserm U. 30, Hôpital des Enfants-Malades, Paris, France.
Biol Neonate. 1987;52(4):232-40. doi: 10.1159/000242714.
The presence of specific cytosol binding sites for 1,25-(OH)2D3 was evaluated in rat fetal tissues during the last quarter of gestation (days 17-21). The content of 1,25-(OH)2D3-binding sites was low in intestine, brain, liver, spleen, pancreas, sternum and thymus during the period of gestation studied. It was highest in skeleton (ribs and vertebral bodies), kidney and lung from day 19 onwards. In the cytosol of these latter tissues, a high affinity (Kd 0.7-3.6 X 10(-10) M, low capacity [3H]1,25-(OH)2D3 binding was demonstrated and a distinct 2.9- to 3.5-S [3H]1,25-(OH)2D3-binding component was observed. These findings suggest that fetal lung, skeleton and kidney are possibly major target tissues for 1,25-(OH)2D3.
在妊娠最后四分之一阶段(第17 - 21天),对大鼠胎儿组织中1,25 -(OH)₂D₃特异性胞质结合位点的存在情况进行了评估。在所研究的妊娠期内,肠、脑、肝、脾、胰腺、胸骨和胸腺中1,25 -(OH)₂D₃结合位点的含量较低。从第19天起,其在骨骼(肋骨和椎体)、肾脏和肺中的含量最高。在这些后期组织的胞质溶胶中,证明存在高亲和力(解离常数Kd为0.7 - 3.6×10⁻¹⁰ M)、低容量的[³H]1,25 -(OH)₂D₃结合,并观察到一个明显的2.9至3.5 S的[³H]1,25 -(OH)₂D₃结合成分。这些发现表明,胎儿的肺、骨骼和肾脏可能是1,25 -(OH)₂D₃的主要靶组织。